Literature DB >> 9772302

Association of PTPmu with catenins in cancer cells: a possible role for E-cadherin.

S Hiscox1, W G Jiang.   

Abstract

Protein tyrosine phosphorylation and dephosphorylation is regulated by the action of protein tyrosine kinases (PTK) and phosphatases (PTP) respectively. The receptor type phosphatase, PTPmu, is located at the cell surface where it may function to regulate the phosphoryl status of members of the cadherin adhesion complex and thus cadherin function. We have investigated the association of PTPmu with E-cadherin and catenin molecules in human tumour cells and report that PTPmu; is associated with E-cadherin and alpha and beta-catenin in E-cadherin-positive cell lines. However, no association between PTPmu and catenin members could be detected in E-cadherin negative cells. These observations suggest that the association of PTPmu with catenin molecules may occur via E-cadherin rather than a direct interaction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9772302     DOI: 10.3892/ijo.13.5.1077

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  9 in total

1.  E-cadherin promotes retinal ganglion cell neurite outgrowth in a protein tyrosine phosphatase-mu-dependent manner.

Authors:  Samantha A Oblander; Sonya E Ensslen-Craig; Frank M Longo; Susann M Brady-Kalnay
Journal:  Mol Cell Neurosci       Date:  2007-02-02       Impact factor: 4.314

Review 2.  Regulation of signaling by protein-tyrosine phosphatases: potential roles in the nervous system.

Authors:  C O Arregui; J Balsamo; J Lilien
Journal:  Neurochem Res       Date:  2000-01       Impact factor: 3.996

3.  Receptor protein tyrosine phosphatase micro regulates the paracellular pathway in human lung microvascular endothelia.

Authors:  Xiu Fen Sui; Timothy D Kiser; Sang Won Hyun; Daniel J Angelini; Robert L Del Vecchio; Bradford A Young; Jeffrey D Hasday; Lewis H Romer; Antonino Passaniti; Nicholas K Tonks; Simeon E Goldblum
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

4.  Proteolytic cleavage of protein tyrosine phosphatase mu regulates glioblastoma cell migration.

Authors:  Adam M Burgoyne; Polly J Phillips-Mason; Susan M Burden-Gulley; Shenandoah Robinson; Andrew E Sloan; Robert H Miller; Susann M Brady-Kalnay
Journal:  Cancer Res       Date:  2009-08-18       Impact factor: 12.701

5.  BCCIP associates with the receptor protein tyrosine phosphatase PTPmu.

Authors:  Polly J Phillips-Mason; Tracy Mourton; Denice L Major; Susann M Brady-Kalnay
Journal:  J Cell Biochem       Date:  2008-11-01       Impact factor: 4.429

6.  Tumor-derived extracellular mutations of PTPRT /PTPrho are defective in cell adhesion.

Authors:  Jianshi Yu; Scott Becka; Peng Zhang; Xiaodong Zhang; Susann M Brady-Kalnay; Zhenghe Wang
Journal:  Mol Cancer Res       Date:  2008-07       Impact factor: 5.852

7.  PTPmu regulates N-cadherin-dependent neurite outgrowth.

Authors:  S M Burden-Gulley; S M Brady-Kalnay
Journal:  J Cell Biol       Date:  1999-03-22       Impact factor: 10.539

8.  Regulation of adherens junction dynamics by phosphorylation switches.

Authors:  Cristina Bertocchi; Megha Vaman Rao; Ronen Zaidel-Bar
Journal:  J Signal Transduct       Date:  2012-07-12

9.  Protein tyrosine phosphatase µ (PTP µ or PTPRM), a negative regulator of proliferation and invasion of breast cancer cells, is associated with disease prognosis.

Authors:  Ping-Hui Sun; Lin Ye; Malcolm D Mason; Wen G Jiang
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.